Oral vaccine player lays off 27% of staff as it shelves Covid work
After spending much of the past few years touting its experimental Covid-19 vaccine pill, Vaxart is pulling back and shelving all further trials.
It has …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
